Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nordic Multicentre Un-blinded Phase II Randomized Controlled Trial (RCT) Evaluating the Additional Efficacy of Adding Chemotherapy Prior to Resection of a Pancreatic Head Malignancy to Avoid Early Mortality in Those Ultimately Resected

NCT02919787 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.

NCT NCT02919787
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02919787 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nordic Multicentre Un-blinded Phase II Randomized Controlled Trial (RCT) Evaluating the Additional Efficacy of Adding Chemotherapy Prior to Resection of a Pancreatic Head Malignancy to Avoid Early Mortality in Those Ultimately Resected
Lead sponsor
Oslo University Hospital
Phase
Phase 2/3
Overall status
Active, not recruiting
Start date
September 30, 2016
Completion date
April 30, 2026
Enrollment
140 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer